Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date
February 20 2017 - 2:00PM
Amedisys, Inc. (NASDAQ:AMED), announced today that it will report
results for the fourth quarter ended December 31, 2016 after the
market closes on February 28, 2017. The Company will host an
investor conference call to discuss these results at 11:00 a.m. ET
on March 1, 2017.
To participate on the conference call, please call a few minutes
before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412)
902-1028 (Toll). A replay of the conference call will be
available through April 1, 2017. The replay dial-in number is
(877) 660-6853 (Toll-Free) or (201) 612-7415 (Toll) and reference
conference ID #13654607.
A live webcast of the call will be accessible
through our website on our Investor Relations section at the
following web address: http://investors.amedisys.com.
About Amedisys: Amedisys, Inc. is a leading
healthcare at home Company delivering personalized home health,
hospice and personal care. Amedisys is focused on delivering the
care that is best for our patients, whether that is home-based
personal care; recovery and rehabilitation after an operation or
injury; care focused on empowering them to manage a chronic
disease; or hospice care at the end of life. More than 2,200
hospitals and 61,900 physicians nationwide have chosen Amedisys as
a partner in post-acute care. Founded in 1982, headquartered in
Baton Rouge, LA with an executive office in Nashville, TN, Amedisys
is a publicly held company. With more than 16,000 employees, in 420
care centers in 34 states, Amedisys is dedicated to delivering the
highest quality of care to the doorsteps of more than 360,000
patients in need every year. For more information about the
Company, please visit: www.amedisys.com.
We use our company website as a channel of
distribution for important company information. Important
information, including press releases, analyst presentations and
financial information regarding the Company is routinely posted on
and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on
our website home page. Visitors to our website can also register to
receive automated e-mail and other notifications alerting them to
when new information is made available on the Investor Relations
subpage of our website. In addition, we make available on the
Investor Relations subpage of our website (under the link "SEC
filings") free of charge our annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K, ownership
reports on Forms 3, 4 and 5 and any amendments to those reports as
soon as practicable after we electronically file such reports with
the SEC. Further, copies of our Certificate of Incorporation and
Bylaws, our Code of Ethical Business Conduct and the charters for
the Audit, Compensation, Nominating and Corporate Governance,
Quality of Care and Compliance and Ethics Committees of our Board
are also available on the Investor Relations subpage of our website
(under the link "Corporate Governance").
Contact:
Amedisys, Inc.
David Castille
Managing Director, Finance and Assistant Treasurer
225.299.3665
david.castille@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024